1.
Clin Case Rep
; 10(5): e05766, 2022 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-35540715
RESUMEN
Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy-induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot-Marie-Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.